| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.9 |
| mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
0.0059 |
0.9 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
| mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
blebbistatin |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.9 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
| mRNA |
TAK-715 |
GDSC1000 |
pan-cancer |
AAC |
-0.0052 |
0.9 |